Acadian Asset Management’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,911
Closed -$27K 2245
2025
Q4
$27K Buy
+5,911
New +$26.8K ﹤0.01% 1874

Other funds holding SOPH

Acadian Asset Management's SOPH Position: Q1 2026 in Review

Acadian Asset Management sold out of SOPHiA GENETICS (SOPH) in Q1 2026, closing a stake of 5,911 shares — an estimated $27K sold.

Acadian Asset Management first reported a position in SOPH in Q4 2025 and held it in 1 quarter. The position peaked at $27K in Q4 2025. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.

  • Acadian Asset Management reported no remaining SOPHiA GENETICS position as of Q1 2026 after selling out during the quarter.
  • Acadian Asset Management sold 5,911 SOPHiA GENETICS shares in Q1 2026, an estimated $27K.
  • Acadian Asset Management first reported a position in SOPHiA GENETICS in Q4 2025 and held it in 1 quarter.
  • Acadian Asset Management's SOPHiA GENETICS position peaked at $27K in Q4 2025.
  • 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.